Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$224.73 - $338.64 $1.39 Million - $2.09 Million
-6,185 Reduced 66.04%
3,181 $787,000
Q1 2022

May 13, 2022

BUY
$277.25 - $366.29 $217,641 - $287,537
785 Added 9.15%
9,366 $3.1 Million
Q4 2021

Feb 11, 2022

SELL
$300.63 - $371.35 $498,444 - $615,698
-1,658 Reduced 16.19%
8,581 $3.08 Million
Q3 2021

Nov 12, 2021

BUY
$310.19 - $376.2 $2.2 Million - $2.67 Million
7,094 Added 225.56%
10,239 $3.33 Million
Q2 2021

Aug 10, 2021

SELL
$262.71 - $351.17 $307,633 - $411,220
-1,171 Reduced 27.13%
3,145 $982,000
Q1 2021

May 07, 2021

SELL
$285.92 - $355.13 $1.15 Million - $1.42 Million
-4,011 Reduced 48.17%
4,316 $1.38 Million
Q4 2020

Feb 12, 2021

BUY
$251.88 - $324.2 $731,207 - $941,152
2,903 Added 53.52%
8,327 $2.7 Million
Q3 2020

Nov 12, 2020

BUY
$255.22 - $317.0 $258,793 - $321,438
1,014 Added 22.99%
5,424 $1.5 Million
Q2 2020

Aug 12, 2020

BUY
$141.4 - $257.09 $156,247 - $284,084
1,105 Added 33.43%
4,410 $1.07 Million
Q1 2020

May 12, 2020

SELL
$130.51 - $196.01 $265,326 - $398,488
-2,033 Reduced 38.09%
3,305 $480,000
Q4 2019

Feb 13, 2020

SELL
$159.31 - $223.54 $1.75 Million - $2.45 Million
-10,982 Reduced 67.29%
5,338 $911,000
Q3 2019

Nov 12, 2019

BUY
$175.89 - $279.23 $1.06 Million - $1.68 Million
6,010 Added 58.29%
16,320 $2.9 Million
Q2 2019

Aug 13, 2019

SELL
$250.96 - $284.94 $120,962 - $137,341
-482 Reduced 4.47%
10,310 $2.69 Million
Q1 2019

May 14, 2019

SELL
$276.39 - $362.25 $1.05 Million - $1.38 Million
-3,816 Reduced 26.12%
10,792 $3.08 Million
Q4 2018

Feb 13, 2019

BUY
$281.08 - $444.25 $618,376 - $977,350
2,200 Added 17.73%
14,608 $4.75 Million
Q3 2018

Nov 13, 2018

SELL
$354.53 - $449.75 $6.98 Million - $8.85 Million
-19,683 Reduced 61.33%
12,408 $5.58 Million
Q2 2018

Aug 13, 2018

BUY
$278.07 - $446.21 $8.92 Million - $14.3 Million
32,091 New
32,091 $13.1 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.